These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22898831)

  • 1. Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination.
    Jin HJ; Sui HX; Wang YN; Gao FG
    J Clin Immunol; 2013 Jan; 33(1):246-54. PubMed ID: 22898831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine stimulated bone marrow-derived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway.
    Jin HJ; Li HT; Sui HX; Xue MQ; Wang YN; Wang JX; Gao FG
    Immunol Lett; 2012 Aug; 146(1-2):40-9. PubMed ID: 22546501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer.
    Gao FG; Li HT; Li ZJ; Gu JR
    J Clin Immunol; 2011 Feb; 31(1):80-8. PubMed ID: 20957418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo nicotine stimulation augments the efficacy of therapeutic bone marrow-derived dendritic cell vaccination.
    Gao FG; Wan da F; Gu JR
    Clin Cancer Res; 2007 Jun; 13(12):3706-12. PubMed ID: 17575236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells.
    Weng X; Kuang Y; Liu X; Chen Z; Zhu H; Chen H; Jiang B; Shen H
    Braz J Med Biol Res; 2011 Mar; 44(3):186-92. PubMed ID: 21243315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses.
    Kuang Y; Weng X; Liu X; Zhu H; Chen Z; Jiang B; Chen H
    Cancer Lett; 2010 Jul; 293(2):254-62. PubMed ID: 20149524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 T-cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T-cell responses resulting in potent antitumor effects.
    Park HM; Sohn HJ; Kim YJ; Cho HI; Kim TG
    Vaccine; 2014 Dec; 32(51):6919-6926. PubMed ID: 25444817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change of immunoactivity of dendritic cells induced by mouse 4-1BBL recombinant adenovirus.
    Youlin K; Xiaodong W; Xiuheng L; Zhiyuan C; Hengcheng Z; Hui C; Botao J
    Yonsei Med J; 2010 Jul; 51(4):594-8. PubMed ID: 20499429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.
    Koorella C; Nair JR; Murray ME; Carlson LM; Watkins SK; Lee KP
    J Biol Chem; 2014 Mar; 289(11):7747-62. PubMed ID: 24415757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide and dose of nicotine determine the effects of nicotine on murine bone marrow-derived dendritic cells.
    Hu SX; Sui HX; Jin HJ; Ni XY; Liu XX; Xue MQ; Zhang Y; Gao FG
    Mol Med Rep; 2012 Apr; 5(4):1005-10. PubMed ID: 22245993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway.
    Wang YY; Yang YW; You X; Deng XQ; Hu CF; Zhu C; Wang JY; Gu JJ; Wang YN; Li Q; Gao FG
    Anal Cell Pathol (Amst); 2015; 2015():741487. PubMed ID: 26351626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K33 only mutant ubiquitin augments bone marrow-derived dendritic cell-mediated CTL priming via PI3K-Akt pathway.
    Liang YY; Liao XY; Jia JJ; Yin YZ; Zhang YH; Gao FG
    Immunology; 2024 Jul; 172(3):486-499. PubMed ID: 38547355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide preferentially induces 4-1BB ligand expression on human monocyte-derived dendritic cells.
    Lee PK; Chang CJ; Lin CM
    Immunol Lett; 2003 Dec; 90(2-3):215-21. PubMed ID: 14687728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.
    Wang R; Freywald A; Chen Y; Xu J; Tan X; Xiang J
    Cell Mol Immunol; 2015 Jul; 12(4):456-65. PubMed ID: 25195511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
    Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.
    Sharma RK; Schabowsky RH; Srivastava AK; Elpek KG; Madireddi S; Zhao H; Zhong Z; Miller RW; Macleod KJ; Yolcu ES; Shirwan H
    Cancer Res; 2010 May; 70(10):3945-54. PubMed ID: 20406989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.